Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The MSD Business Development & Partnering team have been shortlisted in the PraxisAuril and UK Research and Innovation (UKRI) 2019 Knowledge Exchange Awards, in the category of 'Knowledge Exchange Team of the Year'.

The Knowledge Exchange (KE) awards are a new initiative organised by PraxisAuril, the UK’s world-leading professional association for KE practitioners, to celebrate the contribution of KE professionals in enabling and facilitating the societal and economic impact of research. Sponsored by UKRI, the KE Awards recognise and celebrate the people behind the best KE achievements.

The MSD Business Development team have been shortlisted as finalists in the 'KE Team of the Year' category, which recognises a KE team who have excelled in delivering excellent service and value to their institution. Entries are judged on the success of the team including value added, relationships built, teamwork and challenges overcome. The other finalists in the category are the University of Liverpools' Consultancy Team and the University of Birminghams' Business Engagement Team.

The University of Oxford has also been shortlisted in two other categories:

The winners will be announced at the PraxisAuril conference on the evening of Thursday 13 June 2019.

 

About the MSD BUSINESS DEVELOPMENT TEAM

Over the last 8.5 years, the Business Development and Partnering Team within the Medical Sciences Division at Oxford has grown to 13 members and secured over £58M in industry investment through strategic partnerships. The team build and manage multi-year alliances with 14 companies; support major co-location initiatives with key strategic partners; foster a live pipeline of ~70 mature project development discussions, involving 35 companies and provide dedicated management of industry engagement for the NHS through close association with Oxford’s Biomedical Research Centre.

Some of the key relationships that the team have built, supported and enabled are with Novo Nordisk, Celgene, Bayer HealthCare, Elysium Health and Pfizer. Recently the introduction of a dedicated team member to develop our SME engagement strategy has been pivotal in utilising and creating new models to engage effectively with this set of unique companies.

We develop Fellowship schemes as a model for sustaining long-term engagement with international companies including UCB, Celgene, Novo Nordisk and Elysium, and have shared our experiences at international conferences. Additionally, to drive KE and networking we set up an Oxford Industry Fellows Network (over 50 Industry-sponsored Fellows and postdoctoral researchers) to offer opportunities for industry to train fellows, and for fellows to build their networks.

Our Experts in Residence scheme has driven KE in digital health (iWantGreatCare, IBM, Frog Design), surgical technologies (Koli Inc), med tech regulation (OrganOx), drug discovery and development (Evotech, GSK) and continues to grow.

As a large and disperse division with over 3000 researchers, size doesn’t always work to our advantage and can be a barrier to industry interaction. Our team successfully helps companies navigate the division and we have also found the balance between being visible, but also prioritising relationships where we can add most value.

Find out more about the MSD Business Development Team

 

 

Similar stories

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.

Cathy Creswell, David Roberts, and Matthew Costa elected Fellows of Academy of Medical Sciences

Cathy Creswell, Professor of Developmental Clinical Psychology at the Departments of Psychiatry and Experimental Psychology, David Roberts, Professor of Haematology at the Radcliffe Department of Medicine and Consultant Haematologist, and Matthew Costa, Professor of Orthopaedic Trauma Surgery at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, have been elected Fellows of the Academy of Medical Sciences.

Susan Lea and Jordan Raff elected Fellows of the Royal Society

Many congratulations to Susan and Jordan for this prestigious honour, recognising their contributions to structural and centrosome biology, respectively